Reduce your levothyroxine dose by 12.5 to 25 mcg
Your TSH of 0.18 mIU/L indicates you are receiving too much levothyroxine and need a dose reduction. This suppressed TSH level suggests iatrogenic subclinical hyperthyroidism, which can lead to adverse cardiovascular outcomes including atrial fibrillation, increased cardiac mortality, and reduced bone mineral density, particularly if you are older than 60 years 1, 2.
Recommended Dose Adjustment
Decrease your levothyroxine from 100 mcg to either 87.5 mcg or 75 mcg daily 1, 3. The guidelines specify that dose adjustments should be made in increments of 12.5-25 mcg 1.
Which reduction to choose:
- 25 mcg reduction (to 75 mcg): More likely to bring TSH into normal range but carries slightly higher risk of overcorrection
- 12.5 mcg reduction (to 87.5 mcg): More conservative approach with lower risk of causing elevated TSH 4
Based on research showing that 25 mcg reductions from doses ≤175 mcg result in elevated TSH in only 3.8% of patients 4, I recommend reducing to 75 mcg daily as this is more likely to normalize your TSH efficiently.
Important Caveats
Before adjusting the dose, verify:
- Medication adherence: Are you taking it consistently 30-60 minutes before breakfast on an empty stomach with water? 1, 3
- Drug interactions: Are you taking medications that interfere with absorption (calcium, iron, proton pump inhibitors, antacids) within 4 hours of levothyroxine? 1
- Recent weight changes: Significant weight loss decreases levothyroxine requirements 1
- Incorrect administration technique: Studies show 77.4% of patients use incorrect technique, which can falsely suggest need for higher doses 5
If any of these factors are present, correcting them may normalize your TSH without dose reduction 5.
Monitoring Plan
Recheck TSH in 4-8 weeks after dose adjustment 1, 3. The peak therapeutic effect of a levothyroxine dose change takes 4-6 weeks to manifest 3.
Target TSH range:
For non-pregnant adults with primary hypothyroidism, the evidence does not support targeting specific TSH values within the normal reference range 1. Your goal is simply to achieve a TSH within the normal reference range (typically 0.5-4.5 mIU/L) 1.
Special Considerations
If you have cardiac disease or are at risk for atrial fibrillation:
The suppressed TSH is particularly concerning as subclinical hyperthyroidism increases cardiovascular mortality up to 3-fold and all-cause mortality up to 2.2-fold in individuals over 60 years 2. Dose reduction is even more urgent in this population.
If you are pregnant or planning pregnancy:
Different TSH targets apply (first trimester <2.5 mIU/L) 1, but your current suppressed TSH still requires dose reduction.
If symptoms persist after normalization:
Once TSH normalizes, if you continue experiencing hypothyroid symptoms, it may be reasonable to target the lower half of the reference range, though this lacks strong evidence for improved outcomes 2.
Why This Matters
Chronic TSH suppression from levothyroxine overtreatment is associated with increased risk of atrial fibrillation, cardiovascular events, and decreased bone mineral density 2. Studies show that patients on doses >100 mcg have substantially higher rates of suboptimal treatment, with over 45% developing out-of-range TSH values within 6 months 6. Correcting your dose now prevents these long-term complications.